You would like to learn - which objectives the Hessian clusters and networks pursue? - what activities there are in the...

The associated PROXIDRUGS partner Revvity launched a detection kit for quantifying the expression level of RNA-binding motif protein 39...

Today the PROXIDRUGS consortium met to get started with the conceptualization of the second funding period. It was a fruitful day full of...

Join a continuously expanding research-driven partnership focused on innovative therapies for human diseases. Funded within the first...

The PROXIDRUGS community welcomes Judith Frydman (Stanford University, USA) at Goethe University. Judith Frydman was awarded with the...

Revvity, Inc., a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives...

Together with Brenda Schulman, Director at the Max Planck Institute of Biochemistry in Martinsried, PROXIDRUGS speaker Ivan Đikić will...

The list of Highly Cited Researchers identifies pioneers in their respective fields who repeatedly demonstrated significant and broad...

In the latest issue of Cell Chemical Biology, PROXIDRUGS scientists Varun Shah and Ivan Đikić comment on an article published by Simpson...

On October 17th and 18th, the second annual PROXIDRUGS meeting took place in Bad Brückenau. Exciting research results were presented, and...